Neoadjuvant TherapyChemotherapy, AdjuvantChemoradiotherapy, AdjuvantCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingTreatment OutcomeRadiotherapy, AdjuvantRectal NeoplasmsFluorouracilAdenocarcinomaEsophagectomyPancreatic NeoplasmsCisplatinBreast NeoplasmsEsophageal NeoplasmsDisease-Free SurvivalPrognosisSurvival RateTaxoidsPancreatectomyNeoplasm Recurrence, LocalPreoperative CareDeoxycytidinePancreaticoduodenectomyEpirubicinChemoradiotherapySurvival AnalysisRetrospective StudiesDoxorubicinCarcinoma, Squamous CellAntineoplastic AgentsLiver NeoplasmsCA-19-9 AntigenHepatectomyKaplan-Meier EstimateLymphatic MetastasisCarcinoma, Pancreatic DuctalPaclitaxelOrganoplatinum CompoundsAnthracyclinesCyclophosphamideTumor Markers, BiologicalProspective StudiesFollow-Up StudiesTomography, X-Ray ComputedPositron-Emission TomographyLung NeoplasmsLeucovorinRadiotherapy DosageFluorodeoxyglucose F18CystectomyReceptor, erbB-2Predictive Value of TestsEsophagogastric JunctionStomach NeoplasmsMultimodal ImagingLymph Node ExcisionSarcomaOsteosarcomaMetastasectomyAntimetabolites, AntineoplasticColorectal NeoplasmsCarcinoma, Non-Small-Cell LungGastrectomyBiomarkers, PharmacologicalAntibodies, Monoclonal, HumanizedDigestive System Surgical ProceduresNeoplasm, ResidualReceptors, EstrogenMultivariate AnalysisCarcinoma, Ductal, BreastMuscle NeoplasmsRadiotherapyInduction ChemotherapyDrug Administration ScheduleBile Duct NeoplasmsCarcinomaReceptors, ProgesteroneEndosonographyRadiopharmaceuticalsPneumonectomyCholangiocarcinomaAntineoplastic Agents, HormonalNeoplasm InvasivenessRandomized Controlled Trials as TopicCarcinoma, LobularNeoplasm MetastasisImmunohistochemistryTime FactorsMethotrexateFeasibility StudiesBridged CompoundsCarboplatinHypopharyngeal NeoplasmsHepatoblastomaIfosfamideProportional Hazards ModelsVinblastineBone Neoplasms